Therapeutic Approach

The Helix approach relies on standard hospital protocols for collecting a patients’ hematopoietic stem cells. These isolated HSC will be treated in a hospital laboratory setting, under strict FDA approved protocols with reagents supplied by Helix that are specifically designed to correct the patients’ genetic misinformation. Following correction and enhancement of the HSC, the cells are returned to the patient.